vorinostat,pembrolizumab
merck
['vorinostat', 'pembro', 'nsclc', 'sclc']
while at #asco23, dr. andreas saltos discusses the final results of a phase ii randomized trial of first-line pembrolizumab and vorinostat in patients with metastatic nsclc.
learn more #moffittasco 
Moffitt Cancer Center is a global leader in patient care, research and education with a mission to contribute to the prevention and cure of cancer.